MedTrace Logo

Atrial Fibrillation Ablation Registry

NCT04055961 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2023-02-28

No results posted yet for this study

Summary

The Atrial Fibrillation Ablation Registry (AFib Ablation Registry™) is designed to assess the prevalence, demographics, management, and outcomes of patients undergoing percutaneous catheter ablation procedures to treat atrial fibrillation (AF).

Conditions

Interventions

DEVICE

Atrial Fibrillation Ablation

A procedure used to treat an irregular heart rhythm (arrhythmia)

Sponsors & Collaborators

  • Hoag Memorial Hospital Presbyterian

    lead OTHER

Principal Investigators

  • Leila Andres · Hoag Memorial Hospital Presbyterian

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-20
Primary Completion
2025-05-20
Completion
2025-05-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04055961 on ClinicalTrials.gov